Showing 1,801 - 1,820 results of 2,166 for search '"cancer registry"', query time: 0.16s Refine Results
  1. 1801
  2. 1802

    Treatment decision‐making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study by Josianne C. H. B. M. Luijten, Linda Brom, Pauline A. J. Vissers, Yes. A. J. van deWouw, Fabienne A. R. M. Warmerdam, Joos Heisterkamp, Stella Mook, Jamal Oulad Hadj, Marc J. vanDet, Liesbeth Timmermans, Maarten C. C. M. Hulshof, Hanneke W. M. vanLaarhoven, Camiel Rosman, Peter D. Siersema, Marjan J. Westerman, Rob H. A. Verhoeven, Grard A. P. Nieuwenhuijzen

    Published 2022-06-01
    “…Methods To gain an in‐depth understanding of treatment decision‐making, quantitative data (i.e., multidisciplinary team meeting proposal and treatment that was carried out) were collected from the Netherlands Cancer Registry. Changes in the multidisciplinary team meeting proposal and applied treatment comprised changes in the type of treatment option (i.e., curative or palliative, or no change) and were calculated according to the multivariable multilevel probability of undergoing treatment with curative intent (low, middle, and high). …”
    Get full text
    Article
  3. 1803

    The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review by Ambroise Lauby, Olivier Colomban, Pauline Corbaux, Julien Peron, Lilian Van Wagensveld, Witold Gertych, Naoual Bakrin, Pierre Descargues, Jonathan Lopez, Vahan Kepenekian, Olivier Glehen, Charles Andre Philip, Mojgan Devouassoux-Shisheboran, Michel Tod, Gilles Freyer, Benoit You

    Published 2021-12-01
    “…Across seven studies with more than 12,000 patients, including six large randomized clinical trials and a national cancer registry, along with a mega-analysis database with 5842 patients, the modeled CA-125 ELIMination rate constant K (KELIM), the calculation of which is based on the longitudinal kinetics during the first three cycles of platinum-based chemotherapy, was shown to be a reproducible indicator of tumor intrinsic chemosensitivity. …”
    Get full text
    Article
  4. 1804
  5. 1805
  6. 1806

    Impact of the COVID-19 Outbreak—Delayed Referral of Colorectal and Lung Cancer in Primary Care: A National Retrospective Cohort Study by Charles W. Helsper, Carla H. Van Gils, Nicole F. Van Erp, Marinde F. R. Siepman van den Berg, Omar Rogouti, Kristel M. Van Asselt, Otto R. Maarsingh, Jean Muris, Daan Brandenbarg, Sabine Siesling, Niek J. De Wit, Matthew P. Grant, on behalf of the COVID and Cancer Consortium

    Published 2023-02-01
    “…We performed a national retrospective cohort study utilizing primary care records linked to The Netherlands Cancer Registry. For patients with symptomatic colorectal, lung, breast, or melanoma cancer, we manually explored free and coded texts to determine the durations of the primary care (IPC) and secondary care (ISC) diagnostic intervals during the first COVID-19 wave and pre-COVID-19. …”
    Get full text
    Article
  7. 1807

    The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study by Chih‐Chieh Yen, Yi‐Hsin Yang, Hsiu‐Ying Ku, Huang‐Ming Hu, Su‐Shun Lo, Hung‐Chi Chang, Yee Chao, Jen‐Shi Chen, Hsiu‐Po Wang, Tsang‐En Wang, Li‐Yuan Bai, Ming‐Shiang Wu, Chia‐Jui Yen, Li‐Tzong Chen, Yan‐Shen Shan

    Published 2023-08-01
    “…Methods We included patients with clinical Stage II–III gastric cancer who received curative surgery from 2008 to 2017 of Taiwan Cancer Registry. PreWT was defined as the time from endoscopic diagnosis to surgery. …”
    Get full text
    Article
  8. 1808

    Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country by Poh ME, How SH, Ho GF, Pang YK, Hasbullah HH, Tho LM, Muhamad Nor I, Lim BC, Ho KF, Thiagarajan M, Samsudin A, Omar A, Ong CK, Soon SY, Tan JYK, Zainal Abidin MA

    Published 2023-01-01
    “…Using data from a nationwide lung cancer registry, the present study aimed to identify treatment patterns and clinical outcomes of ALK-positive NSCLC in Malaysia.Methods: This retrospective study examined data of patients with ALK-positive NSCLC from 18 major hospitals (public, private, or university teaching hospitals) throughout Malaysia between January 1, 2015 and December 31, 2020 from the National Cardiovascular and Thoracic Surgical Database (NCTSD). …”
    Get full text
    Article
  9. 1809

    Cancer mortality trends after implementation of the national programme for dispensarization of certain groups of the adult population: a population-based study from arkhangelsk, no... by L. E. Valkova, M. L. Levit, V. M. Merabishvili, A. Yu. Pankrateva, M. V. Krupina, D. M. Dubovichenko, A. V. Agaeva, A. Yu. Ryzhov, E. F. Potekhina, M. Yu. Valkov

    Published 2020-12-01
    “…Purpose of the study.To conduct a comparative analysis of the mortality from malignant neoplasms (MNs) detected during the implementation of the oncological component of National Prevention Programme named Dispensarization of certain groups of the adult population (DCGAP) according to the data of the Arkhangelsk Regional Cancer Registry (ARCR) for the period from 2006 to 2019.Materials and methods. …”
    Get full text
    Article
  10. 1810

    Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989–2019Resea... by Carolien C.H.M. Maas, David van Klaveren, Otto Visser, Matthias A.W. Merkx, Hester F. Lingsma, Valery E.P.P. Lemmens, Avinash G. Dinmohamed

    Published 2023-06-01
    “…Methods: From the Netherlands Cancer Registry, we selected adult patients diagnosed with one of the 17 most frequent solid malignancies in the Netherlands during 1989–2019, with survival follow-up until 2022. …”
    Get full text
    Article
  11. 1811

    Prognostic role of epidermal growth factor receptors’ expression in patients with i-ii stage of non-small cell lung cancer by A.P. Kolesnik, A.I. Shevchenko, V.A. Tumansky, A.V. Evseev, M.A. Shishkin

    Published 2013-08-01
    “…Introduction: According to the National Cancer Registry data, referring to the revised data in Ukraine, 17422 new cases of lung cancer and 13498 deaths from this malignant tumor were registered in Ukraine within 2010 [1]. …”
    Get full text
    Article
  12. 1812

    Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky by Quan Chen, Quan Chen, Bin Huang, Bin Huang, Abigail M. Anderson, Eric B. Durbin, Eric B. Durbin, Susanne M. Arnold, Susanne M. Arnold, Jill M. Kolesar, Jill M. Kolesar, Jill M. Kolesar

    Published 2023-08-01
    “…This study aimed to quantify the overall and cancer type-specific risks of SPCs among adult-onset cancer survivors by first primary cancer (FPC) types, residence and sex.MethodsThis retrospective cohort study from the Kentucky Cancer Registry included 148,509 individuals aged 20-84 years diagnosed with FPCs from 2000-2014 (followed until December 31, 2019) and survived at least 5 years. …”
    Get full text
    Article
  13. 1813

    Study on the quality of life among cancer survivors attending a tertiary care cancer center in Malaysia by Roy Rillera Marzo, Sudip Bhattacharya, Soe Soe Aye, Shailesh Tripathi, Thein Win Naing, Maung Maung Soe, Ye Wint Kyaw, Cyril Deeben A.L. Richard Packiam, Donnington Chai Ping Ping, Puteri Maisarah Binti Zolpakar, Vethashini A.P. Selvakumar, Saidatur Raihan Binti Abdul Ali, Auni Fajriyah Binti Hasrudin, Joshua Sutikno

    Published 2022-03-01
    “…According to the Malaysian National Cancer Registry Report (MNCR), between 2007 and 2011, there has been a greater increase in the number of reported cancer cases among females (99.3 per 100,000 people) than males (86.9 cases per 100,000 people). …”
    Get full text
    Article
  14. 1814
  15. 1815

    Social Jetlag and Prostate Cancer Incidence in Alberta’s Tomorrow Project: A Prospective Cohort Study by Liang Hu, Andrew Harper, Emily Heer, Jessica McNeil, Chao Cao, Yikyung Park, Kevin Martell, Geoffrey Gotto, Grace Shen-Tu, Cheryl Peters, Darren Brenner, Lin Yang

    Published 2020-12-01
    “…ATP facilitated data linkage with the Alberta Cancer Registry in June 2018 to determine incident prostate cancer cases (<i>n</i> = 250). …”
    Get full text
    Article
  16. 1816

    Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival by Vinzenz Völkel, Michael Gerken, Kees Kleihues-van Tol, Olaf Schoffer, Veronika Bierbaum, Christoph Bobeth, Martin Roessler, Christoph Reissfelder, Alois Fürst, Stefan Benz, Bettina M. Rau, Pompiliu Piso, Marius Distler, Christian Günster, Judith Hansinger, Jochen Schmitt, Monika Klinkhammer-Schalke

    Published 2023-09-01
    “…Currently, about 50% of colorectal cancer patients in Germany are treated in certified centers. (2) Methods: All analyses are based on population-based clinical cancer registry data of 47.440 colorectal cancer (ICD-10-GM C18/C20) patients treated between 2009 and 2017. …”
    Get full text
    Article
  17. 1817
  18. 1818

    Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application by Bin Lu, Bin Lu, Le Wang, Ming Lu, Ming Lu, Yuhan Zhang, Yuhan Zhang, Jie Cai, Chenyu Luo, Chenyu Luo, Hongda Chen, Min Dai

    Published 2022-04-01
    “…The parameters were calibrated and validated using data from population-based cancer registry data and CRC screening programs. Furthermore, to assess the model’s external validity, we compared the model-derived results to outcome patterns of a sigmoidoscopy screening trial in the UK [UK Flexible Sigmoidoscopy Screening (UKFSS) trial]. …”
    Get full text
    Article
  19. 1819

    Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019Research in contex... by Martha S. Linet, Rochelle E. Curtis, Sara J. Schonfeld, Jacqueline B. Vo, Lindsay M. Morton, Graça M. Dores

    Published 2024-05-01
    “…Methods: For 28,473 chemotherapy-treated AML patients diagnosed at ages ≥20 years in population-based cancer registry areas of the Surveillance, Epidemiology, and End Results Program (2001–2018, followed through 2019), we evaluated 1-month through 5-year relative survival (RS) and 95% confidence intervals (95% CI) using the actuarial method in the SEER∗Stat Survival Session and overall survival (OS) using multivariable Cox regression to estimate proportional hazard ratios (HR) and 95% CI. …”
    Get full text
    Article
  20. 1820

    Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship by Vivian J. Bea, Joan E. Cunningham, Joan E. Cunningham, Joan E. Cunningham, Anthony J. Alberg, Dana Burshell, Dana Burshell, Colleen E. Bauza, Kendrea D. Knight, Tonya R. Hazelton, Heidi Varner, Rita Kramer, Susan Bolick, Deborah Hurley, Catishia Mosley, Marvella E. Ford, Marvella E. Ford

    Published 2018-09-01
    “…This included a unique South Carolina AA subpopulation, the Sea Islanders (SI), culturally isolated and with the lowest European American genetic admixture of any AA group.Methods: Participants (42 EAs, 66 non-SI AAs, 29 SIs), diagnosed between August 2011 and December 2012, were identified through the South Carolina Central Cancer Registry and interviewed by telephone within 21 months of diagnosis. …”
    Get full text
    Article